Skip Navigation

Cardiovascular Research 2005 68(3):344-346; doi:10.1016/j.cardiores.2005.09.010
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zimmermann, W.-H.
Right arrow Articles by Eschenhagen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmermann, W.-H.
Right arrow Articles by Eschenhagen, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Questioning the relevance of circulating cardiac progenitor cells in cardiac regeneration

Wolfram-Hubertus Zimmermann* and Thomas Eschenhagen

Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany

* Corresponding author. Tel.: +49 40 42803 7205; fax: +49 40 42803 5925. Email address: w.zimmermann@uke.uni-hamburg.de

Received 14 September 2005; accepted 28 September 2005

The first 10% of the full text of this article appears below.

See article by Ausoni et al. [10] (pages 394–404) in this issue.


    1. Introduction
 
Regeneration of injured myocardium would offer relief to millions of patients with left ventricular dysfunction. Cell implantation and induction of stem cell-mediated myocardial self-repair represent potential means to achieve myocardial regeneration [1,2]. The latter requires homing of cardiogenic cells to diseased myocardium or activation of resident cardiogenic stem cells. Both mechanisms have been described in the literature and would be preferable to exogenous cell engraftment with its drawbacks of invasive cell harvesting, cell propagation, and invasive cell deposition in the heart [3–6]. However, recent studies questioned the principal capacity of circulating adult stem cells to give rise to cardiac myocytes and support myocardial regeneration . . . [Full Text of this Article]


    2. Finding stem cells in the heart
 

    3. Strengths and limitations of the study
 

    4. Conclusion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing
Cardiovasc Res, February 1, 2009; 81(2): 244 - 252.
[Abstract] [Full Text] [PDF]